HTR1A and bipolar disorder: It is a partial agonist of D2, D3, and 5-HT1A receptors and a 5-HT2A receptor antagonist.386 Aripiprazole is also a drug for bipolar disorders.387 Brexpiprazole, developed by Otsuka, is considered as the pharmacological successor to Aripiprazole.